Notably, expression levels of the m6A methyltransferases METTL3 and METTL14 in CML cell lines are comparable if not higher, as in the case of K562 cells, than that of AML cell lines (Fig. 1A). Here, METTL14 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.